SUMMARY Specific T cell cytotoxicity to Epstein-Barr virus (EBV) infected B cells is reported to be abnormal in rheumatoid arthritis (RA). The regression phenomenon was used to determine whether the immunoregulatory defect in RA is restricted to T cells, B cells, or HLA type. Peripheral blood T and B cells from patients with RA and their HLA identical healthy siblings were mixed in varying ratios with and without EBV, and thymidine incorporation was measured on days 7, 14, and 21. The results suggest that the T cell abnormality is related to disease activity and that an inherent defect exists in the rheumatoid B cell which is independent of disease activity.
The underlying deficiency of immunoregulation in rheumatoid arthritis (RA) is unknown, though disturbances in humoral and cellular immunity are well documented. The Epstein-Barr virus (EBV), originally implicated in the pathogenesis of RA, 2 has since been used to study the cellular immunity defect in RA through its ability to transform B lymphocytes into lymphoblastoid cell lines in vitro. Healthy individuals previously infected with EBV possess specific memory T cells which can abrogate B cell outgrowth in mononuclear cell cultures after superinfection with the virus ('regression'3), whereas rheumatoid T cells appear to show impairment of this ability.47 An alternative explanation is that it is not poor T cell regulation but an inherent defect in rheumatoid B cells which renders them unresponsive to regulation.!"t In this study specific T cell cytotoxicity to EBV infected B cells was measured using blood lymphocytes from patients and their HLA identical siblings to ascertain whether the immunoregulatory defect in RA is governed by B cell or T cell behaviour.
Accepted for publication 1 October 1987. Correspondence to Dr Vivienne R Winrow (Fig. 1) . Regressing cultures scoring 1 (dead cells) or 3/1 (small clusters of regressing, transformed cells amongst dead cells) showed, respectively, background or slightly raised thymidine uptake. Table 2 gives an example referring to Fig. la . Fig. 1 shows the regression assay results obtained with family 1 on day 14 of culture. B cells from the patient with RA were used in Fig. la: more than 75% autologous rheumatoid T cells (T/B ratio of 3/1) were required to prevent B cell outgrowth in contrast with 50% (T/B ratio of 1/1) HLA identical allogeneic normal T cells. This affirms that T cells from the rheumatoid patient show a defective cytotoxic response. This patient's T cells were also less able to control the homologous B cell outgrowth from the HLA identical siblings (Figs lb and c) . Fig. 2 shows the results obtained with family 2 on day 14 of culture. In this family the disease in the patient had been inactive for four years. There was no significant difference in thymidine uptake between the cells of the rheumatoid patient and the unaffected siblings at 14 days.
For both families there were no differences in thymidine uptake at seven days. At 21 days thymidine incorporation showed baseline values in family 1 but in family 2 some thymidine incorporation was Results obtained with family 3 (Table 1) require comment. This patient with RA also had clinically active disease at the time of venepuncture. The cells, however, became contaminated during the manipulations and subsequent culture and, at 14 days, only the plate containing rheumatoid B cells with autologous or healthy allogeneic HLA identical T cells remained uncontaminated. The results were comparable with those in Fig. la , the deficiency in T cell control being apparent at B:T cell ratios of 25:75 (data not shown). At seven days thymidine uptake was similar in both autologous and homologous cultures.
Discussion
Families provide a means of obtaining HLA identical, disease discordant individuals, for whom any differences in the behaviour of their cells can be ascribed to disease rather than HLA type. This study contrasts three families each containing a patient with rheumatoid arthritis and healthy HLA identical siblings, the patients having either active (families 1 and 3) or inactive (family 2) rheumatoid disease.
It has been shown that regression is attributable to both EBV specific T cell cytotoxicity and nonspecific autologous mixed lymphocyte reactions and that much of the thymidine uptake by in vitro EBV infected cells at seven days is due to the concomitant T cell expansion. 16 In a previous study we concluded that enhanced thymidine incorporation at seven days by unfractionated cells from rheumatoid patients was indicative of B cell hyperresponsiveness.() We now have further evidence, however, showing that other cell populations are responsible for the increased thymidine uptake and also that viral dose is an important factor in measurement of this hyperresponsiveness.'7 In this study there was no significant difference in thymidine uptake at seven days between any of the cultures (results not shown). As regression normally occurs 10-14 days after in vitro stimulation, any actively dividing cells present on day 14 in cultures not having completely regressed should be virus infected B cells, and it was at this time that differences in thymidine uptake were noted. Table 2 shows that the amount of thymidine incorporation appeared to represent the degree of regression, though no absolute correlations were made..
The patient in, family 1 with active disease at the time.of,assay presents a picture (Fig. la) typical of results obtained by others using non-HLA matched individuals,5 and the patient in family 3 also showed this pattern of reactivity. In family 2, where the patient had 'burnt out' RA, the picture (Fig. 2a) is quite different, being indicative of normal T cell cytotoxicity. Isolated B cells from both rheumatoid patients, however, formed permanent cell lines in the absence of EBV. This was not true of their histocompatible siblings, confirming our previous conclusion that rheumatoid B cells are abnormal in this respect."'
The outgrowth measured at 21 days in family 2 requires comment. Increased thymidine levels were noted (20 000-40 000 cpm). This may reflect a lack of control by rheumatoid T cells but is more probably due to rheumatoid B cell contamination of the rheumatoid T cell population as the EBV infected rheumatoid T cell population also showed some outgrowth of B cells, which regressed at 20 days. It must be remembered that the cell populations are merely enriched for the various cell types and do not represent pure B and T cells.
One interesting aspect of these results is the age difference of these families. Within each family age matching is reasonably close, but the age differences between families 1 and 2 are considerable, the patient in family 2 being almost 30 years older than the patient in family 1. Most studies measuring age related differences of immunity imply that T cell cytotoxicity is impaired in older individuals. '8 Here, the T cells of the older patient (family 2) behaved efficiently, but the T cells of the younger patient (family 1) were defective. This is consistent with our argument that the poor T cell regulation of the patient in family 1 is disease related. Others have suggested that the 'strength' of regression is related to the degree of matching of major histocompatibility complex class 1 antigens,'9 which is clearly not the explanation of the results in these experiments. It is possible that there are sex related differences, but this study was not designed to assess that problem. Sibling B (F) in family 1 showed some impairment in T cell control of EBV infected B cells (Fig. lb) from sibling A (M). All three siblings in family 2 were female.
Because of the small number of families recruited the information available from this study is limited; it suggests, however, that the inability of rheumatoid T cells to regulate B cell outgrowth is related to disease activity, and studies by Gaston and coworkers lend support to this conclusion.2" Also, it appears that the defect in T cell control in RA is reversible as the T cells of the patient with burnt out RA and those of the HLA identical siblings were equally effective in the regression assay. Recent work, also using disease discordant histo-T cell cytotoxicity to Epstein-Barr virus infected B cells 285 the suppression of IgM production by EBV infected rheumatoid B cells, but no correlations were looked for with disease activity. In our study antibody production was not measured. Nevertheless, the spontaneous production of B cell lines by isolated non-T cells from the patients in families 1 and 2 supports our previous data from limiting dilution analysis, ' suggesting that there is an inherent B cell defect in RA which is disease related but, unlike the rheumatoid T cell defect, independent of disease activity. 
